Risk factors for hepatitis C virus (HCV) infection vary, and there were an estimated 1.75
million new cases worldwide in 2015. The World Health Organization aims for a 90 …

More than two decades of intense research has provided a detailed understanding of
hepatitis C virus (HCV), which chronically infects 2% of the world's population. This effort has …

The discovery of hepatitis C virus (HCV) in 1989 permitted basic research to unravel critical
components of a complex life cycle for this important human pathogen. HCV is a highly …

Hepatitis C virus (HCV) uniquely requires the liver-specific microRNA-122 for replication, yet
global effects on endogenous miRNA targets during infection are unexplored. Here, high …

Exciting progress has recently been made in understanding the replication of hepatitis C
virus, a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma …

Hepatitis C virus (HCV) is a leading cause of liver disease worldwide. With∼ 170 million
individuals infected and current interferon-based treatment having toxic side effects and …

Hepatitis C virus (HCV) is a major cause of liver diseases including liver cirrhosis and
hepatocellular carcinoma. Approximately 3% of the world population is infected with HCV …

We report a new hepatitis C virus (HCV) genotype identified in patients originating from the
Democratic Republic of Congo. The prototype QC69 virus is shown to be a new lineage …

Hepatitis C virus (HCV) infects∼ 2% of the world's population. It is estimated that there are
more than 500,000 new infections annually in Egypt, the country with the highest HCV …

Hepatitis C virus (HCV) is a major cause of liver cirrhosis and hepatocellular carcinoma.
Current antiviral therapy fails to clear infection in a substantial proportion of cases. Drug …